Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®

Company Overview - Establishment Labs is a global medical device company focused on improving women's health and wellness in breast aesthetics and reconstruction through science, engineering, and technology [6] - The company has delivered over four million Motiva® devices to plastic and reconstructive surgeons since 2010, establishing a new standard for safety and patient satisfaction [6] Product Innovation - Motiva Implants® feature the patented SmoothSilk® surface, which enhances biocompatibility and promotes low inflammation, resulting in an industry low capsular contracture rate of 0.5% [1][2] - The implants are designed to adapt to body position changes, maintaining a round shape when lying down and a teardrop shape when standing [1] - Both Motiva SmoothSilk Ergonomix® and SmoothSilk® Round implants aim to provide a natural look and feel while ensuring a high safety profile, with less than 1% device-related complications reported [1][2] Market Presence - Motiva Implants® became available in the US in October 2024, with rapid adoption by top plastic surgeons across the country [2][3] - The company holds over 200 patent applications in 20 separate patent families worldwide, supported by over 100 clinical and scientific studies [2][6] Customer Satisfaction - The implants have achieved over 97% satisfaction rates among patients and surgeons, indicating strong acceptance and positive outcomes [1][2]